CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab

CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab

We compared morphologic computed tomography (CT)-based to metabolic fluoro-deoxy-glucose (FDG) positron emission tomography (PET)/CT-based response evaluation in patients with metastatic colorectal cancer and correlated the findings with survival and KRAS status. From 2006 to 2009, patients were inc...

Full description

Bibliographic Details
Main Authors: Skougaard, Kristin, Johannesen, Helle Hjorth, Nielsen, Dorte, Schou, Jakob Vasehus, Jensen, Benny Vittrup, Høgdall, Estrid V S, Hendel, Helle Westergren
Format: Online
Language:English
Published: Blackwell Publishing Ltd 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302679/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302679/

Similar Items